Associate Director, HCP Marketing - Rare Franchise

Princeton, NJ (Hybrid)

$175K/yr – $219K/yrSenior Level8+ years expFull time

Posted 4 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive HCP marketing and market access for Rett syndrome therapies, shaping strategy and cross-functional execution.

  • Must-have: 8+ years in pharmaceutical/biotech marketing with rare disease experience
  • Standout: Cross-functional collaboration with Medical Affairs, Market Access, and Sales for integrated HCP engagement

Job Description

Drive HCP marketing and market access for Rett syndrome therapies, shaping strategy and cross-functional execution.

  • HCP Marketing Strategy
  • Lead development and implementation of HCP-focused marketing plans for Daybue.
  • Lead unbranded disease education initiatives to increase awareness and understanding of Rett Syndrome among HCPs.
  • Develop compelling messaging and resources to support clinical decision-making.
  • Translate insights into actionable strategies that influence prescribing behavior and treatment adoption.
  • Market Shaping & Competitive Planning
  • Design and execute market shaping strategies to prepare the ecosystem for current and future therapies.
  • Monitor competitive landscape and lead competitive planning efforts to ensure differentiation and readiness.
  • Insights Generation & Market Research
  • Act as the marketing point of contact for market research initiatives.

Requirements

  • Bachelor’s degree in marketing, health care, life science; Master’s degree preferred
  • Minimum of 8 years of progressively responsible experience in pharmaceutical or biotech Marketing
  • 3 years in a product manager role strongly desired
  • Rare Disease experience highly desirable, with understanding of specialty therapeutics addressing significant unmet medical needs
  • Travel required; ability to travel up to 30% of time during peak execution time periods

Preferred

  • Emerging life sciences / start-up experience strongly preferred
  • Rare Disease experience highly desirable (if treating as a preferable attribute)
  • Strong Biopharmaceutical brand management experience and demonstrated track record of success (may be required)
  • Proficient at effectively prioritizing goals and coordinating resources to achieve those goals (may be considered a nice-to-have if not mandatory)

Benefits

  • Competitive base, bonus, new hire and ongoing equity packages
  • Medical, dental, and vision insurance
  • Employer-paid life, disability, business travel and EAP coverage
  • 401(k) Plan with a fully vested company match 1:1 up to 5%
  • Employee Stock Purchase Plan with a 2-year purchase price lock-in
  • 15+ vacation days
  • 13-15 paid holidays, including office closure between December 24th and January 1st
  • 10 days of paid sick time
  • Paid parental leave benefit
  • Tuition assistance
Acadia Pharmaceuticals Inc. logo

Acadia Pharmaceuticals Inc.

3.1 Glassdoor

At Acadia, our mission is to turn scientific promise into meaningful innovation that makes the difference for underserved neurological disorders and rare disease communities around the world. Our commercial portfolio includes FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer's disease psychosis and Lewy body dementia psychosis, along with early-stage programs that address other unmet patient needs.

Founded in 1993
San Diego, California, USA
921 employees (54 in marketing)
43% recommend to a friend
49% CEO approval

Traffic Signals

Monthly Visitors
35.6K
Traffic Source Mix
Search
36.9%
Direct
49.4%
Referral
5.5%
Social
7.3%
Paid
0.7%

Headcount Trend

Current headcount: ~921

Marketing Team

Marketing Team Size
52 (6% of company)
Median Career Experience
20 years
Median Tenure
3.5 years
Marketing Roles Posted (Last 30 Days)
2

Funding

Total Funding
$811.7M
Last Raise
$287.5M
Post IPO Equity, 6 years ago

Funding History

  • Sep 2019
    Post IPO Equity • $287.5M
  • Nov 2018
    Post IPO Equity • $316.2M
  • Jan 2013
    Post IPO Equity • $86.4M

Recent News